Study of Sulfur-35 Labeled Disulfonamides in Mice
Author Information
Author(s): MARY F. ARGUS, TREVA L. SEEPE, NORA GUTIERREZ, KATHLEEN HEWSON, FRANCIS E. RAY
Primary Institution: University of Florida
Hypothesis
Can sulfur-35 labeled disulfonamides localize in tumor tissue more effectively than in normal tissues?
Conclusion
Fluorene-2,7-di-(sulfonamidobenzene)-S35 showed the best tumor localization among the compounds tested.
Supporting Evidence
- Fluorene-2,7-di-(sulfonamidobenzene)-S35 had the highest concentration in tumor tissue at 8 hours.
- Biphenyl-4,4'-di-(sulfonamidobenzene-4-carboxylic acid)-S35 localized better in tumor tissue than in blood cells.
- Biphenyl-4,4'-di-(sulfonamidobenzene-S35-4-sulfonamide) did not show selective tumor affinity.
Takeaway
The study tested new compounds to see if they could find tumors better than normal tissues, and one compound did a really good job.
Methodology
The study involved administering three sulfur-35 labeled disulfonamides to tumor-bearing and tumor-free mice and measuring their distribution in various tissues.
Limitations
The study only tested a limited number of compounds and relied on a specific mouse model.
Participant Demographics
Male CAF/Jax hybrid mice, some with transplanted tumors.
Want to read the original?
Access the complete publication on the publisher's website